Advertisement

Index by author

February 01, 1986; Volume 29,Issue 2

A

  1. Ahlijanian, M K

    1. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
      D M Cooper, C M Bier-Laning, M K Halford, M K Ahlijanian and N R Zahniser
      Molecular Pharmacology February 1986, 29 (2) 113-119;

  2. Antonello, C

    1. A search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives.
      G Palù, M Palumbo, C Antonello, G A Meloni and S Marciani-Magno
      Molecular Pharmacology February 1986, 29 (2) 211-217;

B

  1. Baker, P F

    1. Alpha 2-adrenoceptors do not regulate catecholamine secretion by bovine adrenal medullary cells: a study with clonidine.
      D A Powis and P F Baker
      Molecular Pharmacology February 1986, 29 (2) 134-141;

  2. Bier-Laning, C M

    1. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
      D M Cooper, C M Bier-Laning, M K Halford, M K Ahlijanian and N R Zahniser
      Molecular Pharmacology February 1986, 29 (2) 113-119;

  3. Bigelow, J

    1. Mechanism of binding of a benzomorphan opiate to the acetylcholine receptor from Torpedo electroplaque.
      R E Oswald, L Michel and J Bigelow
      Molecular Pharmacology February 1986, 29 (2) 179-187;

  4. Blackmore, P F

    1. Effect of islet-activating pertussis toxin on the binding characteristics of Ca2+-mobilizing hormones and on agonist activation of phosphorylase in hepatocytes.
      C J Lynch, V Prpic, P F Blackmore and J H Exton
      Molecular Pharmacology February 1986, 29 (2) 196-203;

  5. Butt, T R

    1. Regulation of metallothionein gene expression in mammalian cells by gold compounds.
      T R Butt, E J Sternberg, C K Mirabelli and S T Crooke
      Molecular Pharmacology February 1986, 29 (2) 204-210;

C

  1. Cantoni, O

    1. Differences in the effects of Hg(II) on DNA repair induced in Chinese hamster ovary cells by ultraviolet or X-rays.
      N T Christie, O Cantoni, M Sugiyama, F Cattabeni and M Costa
      Molecular Pharmacology February 1986, 29 (2) 173-178;

  2. Cashman, J R

    1. Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations.
      J R Cashman and D M Ziegler
      Molecular Pharmacology February 1986, 29 (2) 163-167;

  3. Cattabeni, F

    1. Differences in the effects of Hg(II) on DNA repair induced in Chinese hamster ovary cells by ultraviolet or X-rays.
      N T Christie, O Cantoni, M Sugiyama, F Cattabeni and M Costa
      Molecular Pharmacology February 1986, 29 (2) 173-178;

  4. Christie, N T

    1. Differences in the effects of Hg(II) on DNA repair induced in Chinese hamster ovary cells by ultraviolet or X-rays.
      N T Christie, O Cantoni, M Sugiyama, F Cattabeni and M Costa
      Molecular Pharmacology February 1986, 29 (2) 173-178;

  5. Cooper, D M

    1. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
      D M Cooper, C M Bier-Laning, M K Halford, M K Ahlijanian and N R Zahniser
      Molecular Pharmacology February 1986, 29 (2) 113-119;

  6. Costa, M

    1. Differences in the effects of Hg(II) on DNA repair induced in Chinese hamster ovary cells by ultraviolet or X-rays.
      N T Christie, O Cantoni, M Sugiyama, F Cattabeni and M Costa
      Molecular Pharmacology February 1986, 29 (2) 173-178;

  7. Crooke, S T

    1. Regulation of metallothionein gene expression in mammalian cells by gold compounds.
      T R Butt, E J Sternberg, C K Mirabelli and S T Crooke
      Molecular Pharmacology February 1986, 29 (2) 204-210;

D

  1. Daly, J W

    1. A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine.
      K A Jacobson, K L Kirk, W L Padgett and J W Daly
      Molecular Pharmacology February 1986, 29 (2) 126-133;

E

  1. Exton, J H

    1. Effect of islet-activating pertussis toxin on the binding characteristics of Ca2+-mobilizing hormones and on agonist activation of phosphorylase in hepatocytes.
      C J Lynch, V Prpic, P F Blackmore and J H Exton
      Molecular Pharmacology February 1986, 29 (2) 196-203;

H

  1. Halford, M K

    1. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
      D M Cooper, C M Bier-Laning, M K Halford, M K Ahlijanian and N R Zahniser
      Molecular Pharmacology February 1986, 29 (2) 113-119;

  2. Harden, T K

    1. H1-histamine receptors on human astrocytoma cells.
      N Nakahata, M W Martin, A R Hughes, J R Hepler and T K Harden
      Molecular Pharmacology February 1986, 29 (2) 188-195;

  3. Hartig, P R

    1. Solubilization and characterization of the serotonin 5-HT1c site from pig choroid plexus.
      K A Yagaloff and P R Hartig
      Molecular Pharmacology February 1986, 29 (2) 120-125;

  4. Heimbrook, D C

    1. Biochemistry of misonidazole reduction by NADPH-cytochrome c (P-450) reductase.
      D C Heimbrook and A C Sartorelli
      Molecular Pharmacology February 1986, 29 (2) 168-172;

  5. Hepler, J R

    1. H1-histamine receptors on human astrocytoma cells.
      N Nakahata, M W Martin, A R Hughes, J R Hepler and T K Harden
      Molecular Pharmacology February 1986, 29 (2) 188-195;

  6. Hinson, J A

    1. Horseradish peroxidase-catalyzed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione.
      D W Potter, D W Miller and J A Hinson
      Molecular Pharmacology February 1986, 29 (2) 155-162;

  7. Hughes, A R

    1. H1-histamine receptors on human astrocytoma cells.
      N Nakahata, M W Martin, A R Hughes, J R Hepler and T K Harden
      Molecular Pharmacology February 1986, 29 (2) 188-195;

J

  1. Jacobson, K A

    1. A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine.
      K A Jacobson, K L Kirk, W L Padgett and J W Daly
      Molecular Pharmacology February 1986, 29 (2) 126-133;

K

  1. Kamaya, H

    1. Anesthetic-protein interaction: surface potential of bovine serum albumin estimated by a pH-sensitive dye.
      T Mashimo, H Kamaya and I Ueda
      Molecular Pharmacology February 1986, 29 (2) 149-154;

  2. Kirk, K L

    1. A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine.
      K A Jacobson, K L Kirk, W L Padgett and J W Daly
      Molecular Pharmacology February 1986, 29 (2) 126-133;

L

  1. Lynch, C J

    1. Effect of islet-activating pertussis toxin on the binding characteristics of Ca2+-mobilizing hormones and on agonist activation of phosphorylase in hepatocytes.
      C J Lynch, V Prpic, P F Blackmore and J H Exton
      Molecular Pharmacology February 1986, 29 (2) 196-203;

M

  1. Marciani-Magno, S

    1. A search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives.
      G Palù, M Palumbo, C Antonello, G A Meloni and S Marciani-Magno
      Molecular Pharmacology February 1986, 29 (2) 211-217;

  2. Martin, M W

    1. H1-histamine receptors on human astrocytoma cells.
      N Nakahata, M W Martin, A R Hughes, J R Hepler and T K Harden
      Molecular Pharmacology February 1986, 29 (2) 188-195;

  3. Mashimo, T

    1. Anesthetic-protein interaction: surface potential of bovine serum albumin estimated by a pH-sensitive dye.
      T Mashimo, H Kamaya and I Ueda
      Molecular Pharmacology February 1986, 29 (2) 149-154;

  4. Meloni, G A

    1. A search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives.
      G Palù, M Palumbo, C Antonello, G A Meloni and S Marciani-Magno
      Molecular Pharmacology February 1986, 29 (2) 211-217;

  5. Michel, L

    1. Mechanism of binding of a benzomorphan opiate to the acetylcholine receptor from Torpedo electroplaque.
      R E Oswald, L Michel and J Bigelow
      Molecular Pharmacology February 1986, 29 (2) 179-187;

  6. Miller, D W

    1. Horseradish peroxidase-catalyzed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione.
      D W Potter, D W Miller and J A Hinson
      Molecular Pharmacology February 1986, 29 (2) 155-162;

  7. Mirabelli, C K

    1. Regulation of metallothionein gene expression in mammalian cells by gold compounds.
      T R Butt, E J Sternberg, C K Mirabelli and S T Crooke
      Molecular Pharmacology February 1986, 29 (2) 204-210;

N

  1. Nakahata, N

    1. H1-histamine receptors on human astrocytoma cells.
      N Nakahata, M W Martin, A R Hughes, J R Hepler and T K Harden
      Molecular Pharmacology February 1986, 29 (2) 188-195;

O

  1. Oswald, R E

    1. Mechanism of binding of a benzomorphan opiate to the acetylcholine receptor from Torpedo electroplaque.
      R E Oswald, L Michel and J Bigelow
      Molecular Pharmacology February 1986, 29 (2) 179-187;

P

  1. Padgett, W L

    1. A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine.
      K A Jacobson, K L Kirk, W L Padgett and J W Daly
      Molecular Pharmacology February 1986, 29 (2) 126-133;

  2. Palù, G

    1. A search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives.
      G Palù, M Palumbo, C Antonello, G A Meloni and S Marciani-Magno
      Molecular Pharmacology February 1986, 29 (2) 211-217;

  3. Palumbo, M

    1. A search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives.
      G Palù, M Palumbo, C Antonello, G A Meloni and S Marciani-Magno
      Molecular Pharmacology February 1986, 29 (2) 211-217;

  4. Potter, D W

    1. Horseradish peroxidase-catalyzed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione.
      D W Potter, D W Miller and J A Hinson
      Molecular Pharmacology February 1986, 29 (2) 155-162;

  5. Powis, D A

    1. Alpha 2-adrenoceptors do not regulate catecholamine secretion by bovine adrenal medullary cells: a study with clonidine.
      D A Powis and P F Baker
      Molecular Pharmacology February 1986, 29 (2) 134-141;

  6. Prpic, V

    1. Effect of islet-activating pertussis toxin on the binding characteristics of Ca2+-mobilizing hormones and on agonist activation of phosphorylase in hepatocytes.
      C J Lynch, V Prpic, P F Blackmore and J H Exton
      Molecular Pharmacology February 1986, 29 (2) 196-203;

S

  1. Sartorelli, A C

    1. Biochemistry of misonidazole reduction by NADPH-cytochrome c (P-450) reductase.
      D C Heimbrook and A C Sartorelli
      Molecular Pharmacology February 1986, 29 (2) 168-172;

  2. Snyder, S H

    1. Characterization of angiotensin converting enzyme by [3H]captopril binding.
      S M Strittmatter and S H Snyder
      Molecular Pharmacology February 1986, 29 (2) 142-148;

  3. Sternberg, E J

    1. Regulation of metallothionein gene expression in mammalian cells by gold compounds.
      T R Butt, E J Sternberg, C K Mirabelli and S T Crooke
      Molecular Pharmacology February 1986, 29 (2) 204-210;

  4. Strittmatter, S M

    1. Characterization of angiotensin converting enzyme by [3H]captopril binding.
      S M Strittmatter and S H Snyder
      Molecular Pharmacology February 1986, 29 (2) 142-148;

  5. Sugiyama, M

    1. Differences in the effects of Hg(II) on DNA repair induced in Chinese hamster ovary cells by ultraviolet or X-rays.
      N T Christie, O Cantoni, M Sugiyama, F Cattabeni and M Costa
      Molecular Pharmacology February 1986, 29 (2) 173-178;

U

  1. Ueda, I

    1. Anesthetic-protein interaction: surface potential of bovine serum albumin estimated by a pH-sensitive dye.
      T Mashimo, H Kamaya and I Ueda
      Molecular Pharmacology February 1986, 29 (2) 149-154;

Y

  1. Yagaloff, K A

    1. Solubilization and characterization of the serotonin 5-HT1c site from pig choroid plexus.
      K A Yagaloff and P R Hartig
      Molecular Pharmacology February 1986, 29 (2) 120-125;

Z

  1. Zahniser, N R

    1. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
      D M Cooper, C M Bier-Laning, M K Halford, M K Ahlijanian and N R Zahniser
      Molecular Pharmacology February 1986, 29 (2) 113-119;

  2. Ziegler, D M

    1. Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations.
      J R Cashman and D M Ziegler
      Molecular Pharmacology February 1986, 29 (2) 163-167;
Back to top

In this issue